Pages that link to "Q37039441"

The following pages link to PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative (Q37039441):

Displaying 31 items.

• The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception (Q27006831) (← links)
• The Alzheimer's disease neuroimaging initiative: progress report and future plans (Q28749585) (← links)
• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (Q30971403) (← links)
• The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes (Q33842492) (← links)
• Biological heterogeneity in ADNI amnestic mild cognitive impairment (Q33882478) (← links)
• Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline (Q33987715) (← links)
• Comparing predictors of conversion and decline in mild cognitive impairment (Q34003436) (← links)
• The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. (Q34065449) (← links)
• Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume (Q34101122) (← links)
• Predicting missing biomarker data in a longitudinal study of Alzheimer disease (Q34227629) (← links)
• Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects (Q34458184) (← links)
• The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function (Q34674417) (← links)
• Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative (Q34717865) (← links)
• Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease (Q34802970) (← links)
• Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment (Q35224265) (← links)
• Homocysteine effects on brain volumes mapped in 732 elderly individuals (Q35340452) (← links)
• Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative (Q35358229) (← links)
• Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease (Q35611460) (← links)
• Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression (Q35775390) (← links)
• Plasma biomarkers of depressive symptoms in older adults (Q35844316) (← links)
• Vascular burden and Alzheimer disease pathologic progression (Q36252244) (← links)
• Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution (Q36509268) (← links)
• Cortical signatures of cognition and their relationship to Alzheimer's disease (Q36558019) (← links)
• Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly (Q36702716) (← links)
• Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals (Q36943464) (← links)
• Effect of cognitive reserve markers on Alzheimer pathologic progression (Q37100140) (← links)
• Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. (Q37114944) (← links)
• Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment. (Q38992067) (← links)
• Longitudinal Change of Biomarkers in Cognitive Decline (Q41719639) (← links)
• Partial least squares correlation of multivariate cognitive abilities and local brain structure in children and adolescents (Q43571963) (← links)
• Commentary on “Biomarkers in Alzheimer's disease drug development.” The view from Alzheimer's Disease Neuroimaging Initiative (Q46399091) (← links)